Results Healthcare   |   Results International

Market Sectors

Our deeply established relationships in the pharmaceutical industry makes us the unrivalled advisor for your cross-border transaction

Life Sciences

The life sciences sector – a cornerstone practice for the Results Healthcare team where we have a track record in advising large multinationals to smaller entrepreneurial organisations – is broad, complex and represents a major component of the healthcare and the wider global economy. Market drivers including an ageing population, a growing global capacity to prioritise and pay for healthcare aligned with an increase in chronic diseases ensure a continued stream of new opportunities and growth for businesses in the life sciences. Our passion for the sector is underpinned by our extensive technical and industry knowledge, deep relationships and an outstanding track record in delivering the best outcomes for our clients.

The Results Healthcare team is dedicated to advising large pharma corporates and smaller biotech businesses as well as companies which provide direct technical services to these companies, on bringing innovative drugs and treatments to market for the benefit of patients and society. Our extensive international relationships in the pharma and biotech industry sets us apart from our competitors and our focus on supporting our clients in their strategic initiatives to create new business models, drive external growth and increase profitability makes us the unrivalled advisor for the sector.

Contract research organisations (CROs) and contract manufacturing organisations (CMOs) are among the strongest growth sectors of the pharmaceutical industry, with many firms experiencing double-digit annual growth. We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

Our team has a strong track-record having advised on some of the most important deals in the space including INC Research on signing its definitive merger agreement with inVentiv, GHO Capital, on its acquisition of Sterling Pharma Solutions and Linguamatics on its acquisition by IQVIA.

A combination of our deep sector knowledge and long-standing industry relationships enables us to get the best outcomes for our clients.

The medical technology sector (medtech) has long benefited from rising demand from demographic factors and the rapid expansion of international markets. More recently, innovation has created the opportunity for step change growth, with the advent of ‘smart devices’ and the introduction of digital technology to the bedside and the operating theatre.

Results Healthcare, with our international capability and deep understanding of healthcare systems in multiple territories, is ideally positioned to support clients to make the most of the growth opportunities in the manufacture, supply and distribution of medical equipment and consumables.

11 May 2021

Results Healthcare has advised Novartis on its strategic alliance with BASF

Results Healthcare is delighted to have been the exclusive advisor to leading global medicines company Novartis, on its strategic alliance with…

18 Mar 2021

Results Healthcare advised Ajinomoto Bio-Pharma Services on the licencing of its Crystalomics Formulation Technology to Kyowa Kirin

Results Healthcare is delighted to have acted as exclusive advisor to Ajinomoto Bio-Pharma Services, a fully integrated contract development and…

13 May 2021

Results Healthcare has advised Orphan Reach on its acquisition by Emmes

Results Healthcare is delighted to have been the exclusive advisor to Orphan Reach, a Clinical Research Organisation (CRO) dedicated to…

18 Mar 2021

CRO Sector Update: March 2021

M&A and valuations in the CRO sector – March 2021 The level of impact that Covid-19 has had on M&A…

15 Nov 2019

Private equity appetite for the life sciences sector

Private equity firms are finding more creative ways to increase their investment in the life sciences sector.  The life sciences…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:


Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office